Knife handle Australia - English - Department of Health (Therapeutic Goods Administration)

knife handle

ansell ltd t/a ansell healthcare - 12235 - knife handle - a metal surgical instrument designed to mount a blade capable of cutting or dissecting tissue.

Marker, surgical, skin, single use Australia - English - Department of Health (Therapeutic Goods Administration)

marker, surgical, skin, single use

ansell ltd t/a ansell healthcare - 37465 - marker, surgical, skin, single use - an instrument which utilizes non-toxic ink to delineate areas on the skin.

Rack, counter, surgical instrument Australia - English - Department of Health (Therapeutic Goods Administration)

rack, counter, surgical instrument

ansell ltd t/a ansell healthcare - 37846 - rack, counter, surgical instrument - a device used to remove the scalpel blade from the handle and maintain a count of blades, so as to prevent a blade from being inadvertently left in a patient.

Scalpel, one-piece, single use Australia - English - Department of Health (Therapeutic Goods Administration)

scalpel, one-piece, single use

ansell ltd t/a ansell healthcare - 47569 - scalpel, one-piece, single use - a sterile surgical instrument constructed as a one-piece handle and scalpel blade used to manually cut or dissect tissue.

VIVOTIF-B capsule United States - English - NLM (National Library of Medicine)

vivotif-b capsule

rebel distributors corp - salmonella enterica subsp. enterica serovar typhi (unii: 760t5r8b3o) (salmonella enterica subsp. enterica serovar typhi - unii:760t5r8b3o) - salmonella enterica subsp. enterica serovar typhi 2 [cfu] - vivotif (typhoid vaccine live oral ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by salmonella typhi . routine typhoid vaccination is not recommended in the united states of america. selective immunization against typhoid fever is recommended for the following groups: 1) travelers to areas in which there is a recognized risk of exposure to s. typhi , 2) persons with intimate exposure (e.g. household contact) to a s. typhi carrier, and 3) microbiology laboratorians who work frequently with s. typhi (7). there is no evidence to support the use of typhoid vaccine to control common source outbreaks, disease following natural disasters or in persons attending rural summer camps. not all recipients of vivotif will be fully protected against typhoid fever. vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms. the vaccine will not afford protection against species of salmonella other than salmonella